Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 May-Jun;64(3):197-200, 165, 228.

A comparative study of midazolam to meperidine/promethazine as an IM sedative technique for the pediatric dental patient

A T Downs  1 , J Dembo, G Ferretti, T D Lyons, A Pelphery
Affiliations
  • PMID: 9262801
Clinical Trial

A comparative study of midazolam to meperidine/promethazine as an IM sedative technique for the pediatric dental patient

A T Downs et al. ASDC J Dent Child. 1997 May-Jun.

Abstract

This study evaluated the efficacy and safety of midazolam (0.2 mg/kg) as an IM sedative agent in the pediatric population as compared to the standard IM meperidine (2.0 mg/kg)/promethazine (1.0 mg/kg) sedation technique. Ten pediatric dental patients, ASA Class I, were evaluated in this double-blind, randomized, crossover study. The patients ranged in age from two to four years. Vital signs, sedation levels, and anxiety levels were evaluated. Midazolam was shown to be safe, but the inferior drug compared to the standard IM meperidine/promethazine sedation technique.

PubMed Disclaimer

MeSH terms